Combination with Metformin or Metformin with Sulfonylurea In a 30-week, open-label trial (NCT02128932), 1089 patients with type 2 diabetes mellitus were randomized to semaglutide 0.5 mg once weekly, semaglutide 1 mg once weekly, or insulin glargine once daily on a background of metformin (48%) or metformin and sulfonylurea (51%)
This includes a focus on whole foods, such as lean proteins, whole grains, vegetables, and fruits
Second, metabolic/bariatric surgery has been proven to be the most effective treatment in terms of weight loss and improvement in all associated comorbidities
Few small RCTs suggested histological improvements in terms of hepatocellular inflammation (especially ballooning) and beneficial effects on liver fibrosis [103106]
These results suggested that TC- P